AI assistant
Sending…
GILEAD SCIENCES, INC. — Director's Dealing 2019
Apr 25, 2019
29828_dirs_2019-04-25_95a746cd-4bf0-48a8-867c-1c32dae42df7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: GILEAD SCIENCES INC (GILD)
CIK: 0000882095
Period of Report: 2019-04-24
Reporting Person: Lofton Kevin E (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-04-24 | Common Stock | M | 13208 | $24.905 | Acquired | 43332 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-04-24 | Non-qualified Stock Option (Right to Buy) | $24.905 | M | 13208 | Disposed | 2019-07-29 | Common Stock (13208) | Direct |
Footnotes
F1: The options vested quarterly over the first year of service and were fully vested on July 29, 2010.
More from GILEAD SCIENCES, INC.
Regulatory Filings
2026
May 20
Prospectus
2026
May 18
Regulatory Filings
2026
May 14
Prospectus
2026
May 14
Regulatory Filings
2026
May 8
Registration Form
2026
May 7
Interim / Quarterly Report
2026
May 7
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 4
Major Shareholding Notification
2026
Apr 30